The Laboratory  shall note any unusual  condition of the Sample and record such condition(s) in the Test Report in ADAMS;  − Any Samples delivered to the Laboratory  in tubes containing an anti -coagulant (for example, ABP blood Samples  collected in EDTA tubes), or as separated plasma, shall not be analyzed for Markers of the Endocrine Module;  − The Laboratory  shall notify and seek advice from the Testing Authority  regarding rejection or Analytical Testing of Samples for which irregularities are noted (see ISL 1).